Papcup raises £45k from Diversity X Ventures to develop its women's health biosensor platform.
Diversity X Ventures has provided its debut investment to back the diagnostic startup.
£45.0K
Papcup develops a biosensor platform designed to transform menstrual blood into a non-invasive diagnostic tool for women's health.
Papcup has secured £45k in funding from Diversity X Ventures to support the development of its diagnostic biosensor platform.
The capital marks the inaugural investment for Diversity X Ventures, backing founder Sânziana Foia in her work to provide non-invasive diagnostics using menstrual blood.
The technology aims to address the shortfall in timely women's health testing, targeting issues ranging from fatigue to cervical cancer risk.